Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |
mRNA | GPR137C | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-11 |
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-11 |
mRNA | KIAA1683 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
mRNA | FXYD6 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
mRNA | ZNF616 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-11 |
mRNA | ICA1L | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
mRNA | ZNF253 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-11 |
mRNA | ZNF491 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-11 |
mRNA | CPXM1 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-11 |